Dialysis patients and their families are urged to contact a GranuFlo lawyer today if they suffered catastrophic heart injuries that may be related to GranuFlo and NaturaLyte, two dialysis concentrates that were subject to a product recall in 2012. Already, hundreds of people have filed lawsuits seeking compensation for heart attacks, stroke, cardiac arrest, and sudden cardiac death allegedly associated with the administration of GranuFlo or NaturaLyte during dialysis. Bernstein Liebhard LLP is investigating the GranuFlo recall, and a dialysis attorney with our Firm is available to evaluate your case for free if you would like to explore your legal options. To learn more, please contact our legal staff today by calling .
The public was first informed of the dangers associated with GranuFlo and NaturaLyte in May 2012, when Fresenius Medical Care issued an Urgent Product Notification to dialysis clinics nationwide. According to that notice, inappropriate prescription of either product had been linked to high serum bicarbonate levels in patients undergoing dialysis. According to GranuFlo attorneys, this may contribute to metabolic alkalosis, which is a significant risk factor associated with a number of serious side effects, including:
The U.S. Food & Drug Administration later granted Class I status to the Fresenius notification. According to dialysis lawyers representing plaintiffs in GranuFlo lawsuits, this designation means that both GranuFlo and NaturaLyte have the potential to cause serious injury or death.
GranuFlo lawsuits accuse Fresenius Medical Care of failing to provide patients and doctors with adequate warnings of the heart risks associated with GranuFlo and NaturaLyte. They also allege that the company was aware of these dangers long before the GranuFlo and NaturaLyte recall was announced. In November 2011, months before it issued its Urgent Product Notification, the company sent a memo to medical staff at dialysis clinics in the Fresenius network advising that dosage of both be adjusted in order to avoid elevated bicarbonate levels. However, thousands of dialysis centers outside of the company’s network that also used GranuFlo and NaturaLyte did not receive a similar warning until the March 2012 notification was released. GranuFlo lawyers representing plaintiffs in claims against Fresenius Medical Care are seeking answers as to why this occurred.
If the allegations against Fresenius prove to be true, a dialysis attorney could help you obtain compensation for all of the physical, financial, and emotional damages related to your injury, including:
If you are hesitant to contact a GranuFlo attorney because of concerns that you won’t be able to cover expensive legal fees, please don’t worry. Not only is Bernstein Liebhard LLP offering free case reviews to victims of the GranuFlo and NaturaLyte recall, the Firm is also representing clients in these claims on a contingency basis. This means you will only have to pay legal fees and expenses if your dialysis lawyer is able to secure a judgment or settlement in your favor. Those fees will be taken directly out of your recovery, and will be clearly spelled out in the retainer agreement you sign with the Firm before we initiate any action in your case. If we are unable to secure a favorable resolution in your lawsuit, you will not be expected to pay a single penny in legal fees.
Bernstein Liebhard LLP has successfully represented hundreds of people harmed by dangerous drugs and medical products. Our GranuFlo lawyers would be happy to answer any questions you might have about the litigation stemming from the GranuFlo and NaturaLyte recall. Just contact our office today at for your free legal review.